Chemical formula: C₂₃H₂₄N₄O₄ Molecular mass: 420.18 g/mol PubChem compound: 118253852
Brensocatib is indicated for:
Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Brensocatib is indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in patients 12 years of age and older with two or more exacerbations in the prior 12 months.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Brensocatib is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.